Previous 10 | Next 10 |
Sydney, Australia (ABN Newswire) - Invictus Ops Pty Ltd, a wholly owned subsidiary of NSX-listed VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has contracted Resonance Health Ltd (ASX:RHT) to provide liver-fat quantification services for its clinical study ("Study") ...
Sydney, Australia (ABN Newswire) - Invictus Nutraceuticals, Inc. (Florida, USA), a wholly owned subsidiary of VGI Health Technology Limited (NSX:VTL), is pleased to announce that both NE1-Elite(R) and NE1-Heart(R) are now available for sale on Amazon in the United States. Amazon invests b...
Sydney, Australia (ABN Newswire) - The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 31 December 2021. Status of Patent Ownership In October 2021, VTL was pleased to announce the grant of a divisional patent app...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL), is pleased to announce that its wholly-owned subsidiary, Invictus Biotechnology Pty Ltd, has lodged a new PCT Patent Application titled: 'Transmucosal delivery of tocotrienols' (PCT patent application number: PCT/AU20...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL), a clinical-stage biotechnology company wth delivery platforms for improving the bioavailability and efficacy of tocotrienols (a natural product which is one part of vitamin E) and ENDRA Life Sciences Inc. (NASDAQ:NDRA...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that the Japanese Patent Office intends to grant a patent for the Transmucosal Delivery of Tocotrienols. Previously a patent covering the use of tocotrienols and drug delivery technology for ...
Sydney, Australia (ABN Newswire) - The Directors of VGI Health Technology Limited (NSX:VTL) are pleased to provide the following update for the quarter ending 30 September 2021. Status of Patent Ownership There have been no new patent filings or registrations during this period. T...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has agreed revised terms with cornerstone investor Mr Aiden Jiang for the draw down of $1,500,000 from a previously agreed convertible loan facility. The receipt of the funds is expected ...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has received Human Research Ethics Committee (HREC) approval from The Royal Melbourne Hospital (RMH) for a Phase II clinical study on Non-A...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to present the FY21 Annual Report to Shareholders. FY21 was a productive year for the Company, culiminating in a successful Initial Public Offering (IPO) raising equity of approximately $2,500,000 throug...
News, Short Squeeze, Breakout and More Instantly...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...